The pressure is unlikely to ease soon. Analysts said the recent US tariff hikes, sluggish global demand, and sector-specific challenges could trigger further downgrades in the coming quarters.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.